MergerLinks Header Logo

Request Deal Involvement

Mylan subsidiary Alphapharm acquired South African and Australian prescription portfolio of Aspen for A$188m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

ALPHAPHARM

bidder

ALPHAPHARM

MYLAN NV

bidder

MYLAN NV

ASPEN GLOBAL INCORPORATED

target

ASPEN GLOBAL INCORPORATED

ASPEN AUSTRALIA

target

ASPEN AUSTRALIA

ASPEN PHARMACARE HOLDINGS LTD

vendor

ASPEN PHARMACARE HOLDINGS LTD

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Mylan subsidiary Alphapharm acquired South African and Australian prescription portfolio of Aspen for A$188m.